|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forman D and Burley VJ: Gastric cancer:
Global pattern of the disease and an overview of environmental risk
factors. Best Pract Res Clin Gastroenterol. 20:633–649. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee RC, Feinbaum RL and Ambrost V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carleton M, Cleary MA and Linsley PS:
MicroRNAs and cell cycle regulation. Cell Cycle. 6:2127–2132. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: Rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng Y, Zhang X, Ma Q, Yan R, Qin Y, Zhao
Y, Cheng Y, Yang M, Wang Q, Feng X, et al: MiRNA-194 activates the
Wnt/β-catenin signaling pathway in gastric cancer by targeting the
negative Wnt regulator, SUFU. Cancer Lett. 385:117–127. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou W, Li Y, Gou S, Xiong J, Wu H, Wang
C, Yan H and Liu T: MiR-744 increases tumorigenicity of pancreatic
cancer by activating Wnt/β-catenin pathway. Oncotarget.
6:37557–37569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li T, Lai Q, Wang S, Cai J, Xiao Z, Deng
D, He L, Jiao H, Ye Y, Liang L, et al: MicroRNA-224 sustains
Wnt/β-catenin signaling and promotes aggressive phenotype of
colorectal cancer. J Exp Clin Cancer Res. 35:212016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Taipaleenmäki H, Farina NH, van Wijnen AJ,
Stein JL, Hesse E, Stein GS and Lian JB: Antagonizing miR-218-5p
attenuates Wnt signaling and reduces metastatic bone disease of
triple negative breast cancer cells. Oncotarget. 7:79032–79046.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RA, Masters JR, Nakamura Y, Reid YA,
Reddel RR, et al: Check your cultures! A list of cross-contaminated
or misidentified cell lines. Int J Cancer. 127:1–8. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin HY, Gonzalez-Martin A, Miletic AV, Lai
M, Knight S, Sabouri-Ghomi M, Head SR, Macauley MS, Rickert RC and
Xiao C: Transfection of microRNA mimics should be used with
caution. Front Genet. 6:3402015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song X, Xin N, Wang W and Zhao C:
Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in
gastric carcinogenesis. Oncotarget. 6:35579–35588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nagy TA, Wroblewski LE, Wang D, Piazuelo
MB, Delgado A, Romero-Gallo J, Noto J, Israel DA, Ogden SR, Correa
P, et al: β-Catenin and p120 mediate PPARδ-dependent proliferation
induced by Helicobacter pylori in human and rodent epithelia.
Gastroenterology. 141:553–564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Franco AT, Johnston E, Krishna U, Yamaoka
Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P and
Peek RM Jr: Regulation of gastric carcinogenesis by Helicobacter
pylori virulence factors. Cancer Res. 68:379–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li VS, Ng SS, Boersema PJ, Low TY,
Karthaus WR, Gerlach JP, Mohammed S, Heck AJ, Maurice MM, Mahmoudi
T, et al: Wnt signaling through inhibition of β-catenin degradation
in an intact Axin1 complex. Cell. 149:1245–1256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He X, Semenov M, Tamai K and Zeng X: LDL
receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling:
Arrows point the way. Development. 131:1663–1677. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balciunaite G, Keller MP, Balciunaite E,
Piali L, Zuklys S, Mathieu YD, Gill J, Boyd R, Sussman DJ and
Holländer GA: Wnt glycoproteins regulate the expression of FoxN1,
the gene defective in nude mice. Nat Immunol. 3:1102–1108. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cavallo RA, Cox RT, Moline MM, Roose J,
Polevoy GA, Clevers H, Peifer M and Bejsovec A: Drosophila Tcf and
Groucho interact to repress Wingless signalling activity. Nature.
395:604–608. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eastman Q and Grosschedl R: Regulation of
LEF-1/TCF transcription factors by Wnt and other signals. Curr Opin
Cell Biol. 11:233–240. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang SH, Li N, Wei Y, Li QR and Yu ZP:
β-catenin deacetylation is essential for WNT-induced proliferation
of breast cancer cells. Mol Med Rep. 9:973–978. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Y, Zhang S, Xu Y, Zhang Y, Guan H, Li
X, Li Y and Wang Y: Upregulation of miR-192 inhibits cell growth
and invasion and induces cell apoptosis by targeting TCF7 in human
osteosarcoma. Tumour Biol. 37:15211–15220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nikuševa-Martić T, Serman L, Zeljko M,
Vidas Z, Gašparov S, Zeljko HM, Kosović M and Pećina-Šlaus N:
Expression of secreted frizzled-related protein 1 and 3, T-cell
factor 1 and lymphoid enhancer factor 1 in clear cell renal cell
carcinoma. Pathol Oncol Res. 19:545–551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang K, Zhu S, Liu Y, Dong X, Shi Z,
Zhang A, Liu C, Chen L, Wei J, Pu P, et al: ICAT inhibits
glioblastoma cell proliferation by suppressing Wnt/β-catenin
activity. Cancer Lett. 357:404–411. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tago K, Nakamura T, Nishita M, Hyodo J,
Nagai S, Murata Y, Adachi S, Ohwada S, Morishita Y, Shibuya H, et
al: Inhibition of Wnt signaling by ICAT, a novel
beta-catenin-interacting protein. Genes Dev. 14:1741–1749.
2000.PubMed/NCBI
|
|
29
|
Wang S, Krinks M, Lin K, Luyten FP and
Moos M Jr: Frzb, a secreted protein expressed in the Spemann
organizer, binds and inhibits Wnt-8. Cell. 88:757–766. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kiper POS, Saito H, Gori F, Unger S, Hesse
E, Yamana K, Kiviranta R, Solban N, Liu J, Brommage R, et al:
Cortical-bone fragility - insights from sFRP4 deficiency in Pyle's
disease. N Engl J Med. 374:2553–2562. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ota S, Ishitani S, Shimizu N, Matsumoto K,
Itoh M and Ishitani T: NLK positively regulates Wnt/β-catenin
signalling by phosphorylating LEF1 in neural progenitor cells. EMBO
J. 31:1904–1915. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Townsley FM, Cliffe A and Bienz M: Pygopus
and Legless target Armadillo/beta-catenin to the nucleus to enable
its transcriptional co-activator function. Nat Cell Biol.
6:626–633. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kramps T, Peter O, Brunner E, Nellen D,
Froesch B, Chatterjee S, Murone M, Züllig S and Basler K:
Wnt/wingless signaling requires BCL9/legless-mediated recruitment
of pygopus to the nuclear beta-catenin-TCF complex. Cell.
109:47–60. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paluszczak J, Wiśniewska D,
Kostrzewska-Poczekaj M, Kiwerska K, Grénman R, Mielcarek-Kuchta D
and Jarmuż-Szymczak M: Prognostic significance of the methylation
of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of
sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck
squamous cell carcinomas. Clin Oral Investig. 21:1777–1788. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Amen M, Liu X, Vadlamudi U, Elizondo G,
Diamond E, Engelhardt JF and Amendt BA: PITX2 and beta-catenin
interactions regulate Lef-1 isoform expression. Mol Cell Biol.
27:7560–7573. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vadlamudi U, Espinoza HM, Ganga M, Martin
DM, Liu X, Engelhardt JF and Amendt BA: PITX2, beta-catenin and
LEF-1 interact to synergistically regulate the LEF-1 promoter. J
Cell Sci. 118:1129–1137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Liu S, Zhu H, Zhang W, Zhang G,
Zhou X, Zhou C, Quan L, Bai J, Xue L, et al: FRAT1 overexpression
leads to aberrant activation of beta-catenin/TCF pathway in
esophageal squamous cell carcinoma. Int J Cancer. 123:561–568.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chodaparambil JV, Pate KT, Hepler MR, Tsai
BP, Muthurajan UM, Luger K, Waterman ML and Weis WI: Molecular
functions of the TLE tetramerization domain in Wnt target gene
repression. EMBO J. 33:719–731. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bafico A, Liu G, Yaniv A, Gazit A and
Aaronson SA: Novel mechanism of Wnt signalling inhibition mediated
by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol.
3:683–686. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li FQ, Mofunanya A, Harris K and Takemaru
K: Chibby cooperates with 14-3-3 to regulate beta-catenin
subcellular distribution and signaling activity. J Cell Biol.
181:1141–1154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mao B, Wu W, Davidson G, Marhold J, Li M,
Mechler BM, Delius H, Hoppe D, Stannek P, Walter C, et al: Kremen
proteins are Dickkopf receptors that regulate Wnt/beta-catenin
signalling. Nature. 417:664–667. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kang X, Qi Y, Zuo Y, Wang Q, Zou Y,
Schwartz RJ, Cheng J and Yeh ET: SUMO-specific protease 2 is
essential for suppression of polycomb group protein-mediated gene
silencing during embryonic development. Mol Cell. 38:191–201. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ingham PW and Placzek M: Orchestrating
ontogenesis: Variations on a theme by sonic Ηedgehog. Nat Rev
Genet. 7:841–850. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ingham PW, Nakano Y and Seger C:
Mechanisms and functions of Ηedgehog signalling across the metazoa.
Nat Rev Genet. 12:393–406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Merchant M, Vajdos FF, Ultsch M, Maun HR,
Wendt U, Cannon J, Desmarais W, Lazarus RA, de Vos AM and de
Sauvage FJ: Suppressor of fused regulates Gli activity through a
dual binding mechanism. Mol Cell Biol. 24:8627–8641. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hana Y, Shia Q and Jiang J: Multisite
interaction with Sufu regulates Ci/Gli activity through distinct
mechanisms in Hh signal transduction. Proc Natl Acad Sci USA.
112:6383–6388. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Svärd J, Heby-Henricson K, Persson-Lek M,
Rozell B, Lauth M, Bergström A, Ericson J, Toftgård R and Teglund
S: Genetic elimination of suppressor of fused reveals an essential
repressor function in the mammalian Ηedgehog signaling pathway. Dev
Cell. 10:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Taylor MD, Zhang X, Liu L, Hui CC,
Mainprize TG, Scherer SW, Wainwright B, Hogg D and Rutka JT:
Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT
signaling. Oncogene. 23:4577–4583. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Smith MJ, Beetz C, Williams SG, Bhaskar
SS, O'Sullivan J, Anderson B, Daly SB, Urquhart JE, Bholah Z, Oudit
D, et al: Germline mutations in SUFU cause Gorlin
syndrome-associated childhood medulloblastoma and redefine the risk
associated with PTCH1 mutations. J Clin Oncol. 32:4155–4161. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Brugières L, Remenieras A, Pierron G,
Varlet P, Forget S, Byrde V, Bombled J, Puget S, Caron O, Dufour C,
et al: High frequency of germline SUFU mutations in children with
desmoplastic/nodular medulloblastoma younger than 3 years of age. J
Clin Oncol. 30:2087–2093. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu X, Wang X, Du W, Chen L, Wang G, Cui
Y, Liu Y, Dou Z, Wang H, Zhang P, et al: Suppressor of fused (Sufu)
represses Gli1 transcription and nuclear accumulation, inhibits
glioma cell proliferation, invasion and vasculogenic mimicry,
improving glioma chemo-sensitivity and prognosis. Oncotarget.
5:11681–11694. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lee Y, Kawagoe R, Sasai K, Li Y, Russell
HR, Curran T and McKinnon PJ: Loss of suppressor-of-fused function
promotes tumorigenesis. Oncogene. 26:6442–6447. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yan R, Peng X, Yuan X, Huang D, Chen J, Lu
Q, Lv N and Luo S: Suppression of growth and migration by blocking
the Ηedgehog signaling pathway in gastric cancer cells. Cell Oncol.
36:421–435. 2013. View Article : Google Scholar
|
|
54
|
Chung TK, Lau TS, Cheung TH, Yim SF, Lo
KW, Siu NS, Chan LK, Yu MY, Kwong J, Doran G, et al: Dysregulation
of microRNA-204 mediates migration and invasion of endometrial
cancer by regulating FOXC1. Int J Cancer. 130:1036–1045. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Wijnhoven BP, Hussey DJ, Watson DI, Tsykin
A, Smith CM and Michael MZ: South Australian Oesophageal Research
Group: MicroRNA profiling of Barrett's oesophagus and oesophageal
adenocarcinoma. Br J Surg. 97:853–861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Song Y, Zhao F, Wang Z, Liu Z, Chiang Y,
Xu Y, Gao P and Xu H: Inverse association between miR-194
expression and tumor invasion in gastric cancer. Ann Surg Oncol. 19
Suppl 3:S509–S517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Li Z, Ying X, Chen H, Ye P, Shen Y, Pan W
and Zhang L: MicroRNA-194 inhibits the epithelial-mesenchymal
transition in gastric cancer cells by targeting FoxM1. Dig Dis Sci.
59:2145–2152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Chen X, Wang Y, Zang W, Du Y, Li M and
Zhao G: miR-194 targets RBX1 gene to modulate proliferation and
migration of gastric cancer cells. Tumour Biol. 36:2393–2401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Bao J, Zou JH, Li CY and Zheng GQ: miR-194
inhibits gastric cancer cell proliferation and tumorigenesis by
targeting KDM5B. Eur Rev Med Pharmacol Sci. 20:4487–4493.
2016.PubMed/NCBI
|
|
60
|
Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y,
Yao H, Liu X, Ke Y, Si J, et al: MiR-375 frequently downregulated
in gastric cancer inhibits cell proliferation by targeting JAK2.
Cell Res. 20:784–793. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa
M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, et
al: MicroRNA-375 is downregulated in gastric carcinomas and
regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer
Res. 70:2339–2349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Shiotani A, Uedo N, Iishi H, Murao T,
Kanzaki T, Kimura Y, Kamada T, Kusunoki H, Inoue K and Haruma K: H.
pylori eradication did not improve dysregulation of specific
oncogenic miRNAs in intestinal metaplastic glands. J Gastroenterol.
47:988–998. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Daniels DL and Weis WI: ICAT inhibits
beta-catenin binding to Tcf/Lef-family transcription factors and
the general coactivator p300 using independent structural modules.
Mol Cell. 10:573–584. 2002. View Article : Google Scholar : PubMed/NCBI
|
